The problem–Facet Joint Syndrome (FJS)

FJS, also known as spinal osteoarthritis, spinal arthritis, or facet joint osteoarthritis, is a significant health and economic problem in the United States affecting millions each year. In 2011, Medicare and Medicaid patients alone accounted for approximately 1.8 million injections and RF Rhizotomyablations¹. Unfortunately a high number will have recurring symptoms requiring a follow up intervention each year. That’s because current treatment options are temporary and there is no proven long-lasting option for FJS.

The DenerveX™  system is different. It denervates and removes capsular tissue in one single procedure

Treatment results from the combined effect of a slow moving deburring or polishing action and RF ablation treatment. Using this new technique, the slowly rotating burr removes the targeted facet joint synovial membrane and joint surface while the electrocautery denudes any residual nervous and synovial membrane overlying the joint, effectively removing the end point sensory tissue of the joint.

Indications for Use:DenerveX, in combination with the DenerveX Pro-40 RF Generator unit, is intended for coagulation of soft tissues in spinal applications for selective denervation and tissue destruction procedures, which may be performed on the lumbar, thoracic and cervical (C2-C7) regions of the peripheral nerves and nerve roots for the relief of pain associated with the facet joint.

DenerveX is not currently CE Marked or commercially available in the United States of America.

DenerveX is a trademark of Medovex Corp.
1. Haufe SMW, Mork AR. Endoscopic facet debridement for the treatment of facet arthritic pain — a novel technique. Int J Med Sci. 2010;7(3):120-123.